Nerviano Medical Sciences

Overview

• HeadquartersNerviano, Italy¹
• Websitewww.nervianoms.com/en

See how the biggest companies compare on our leaderboards

Timeline

1. 2004Founded Founded¹

Calendar

Drug trials and FDA: coming up

1. May 30, 2027Phase 1/2 trial readout expected Phase 1/2 trial of NMS-03305293 and Temozolomide in Glioblastoma: primary completion expected May 30, 2027 (ClinicalTrials.gov NCT04910022).²

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Links

• Websitewww.nervianoms.com/en¹
• WikidataQ30280722